Natalie Holles - Insider Trading & Ownership

Entity
Individual
Location
C/O Hyperion Therapeutics, Inc., 2000 Sierra Point Parkway, Suite 400, Brisbane, CA
Summary
The estimated net worth of Natalie Holles is at least $15.6M dollars as of January 17, 2025. Natalie Holles is the CEO, Director of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $15.6M.
All Insider Reports
All Insider Reports

Ownership of Natalie Holles

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
THRD Third Harmonic Bio, Inc. CEO, Director $15.6M -$246K -1.55% Jan 15, 2025
ALLK Allakos Inc. Director May 25, 2021
DAWN Day One Biopharmaceuticals, Inc. Director May 23, 2024
RUBY Rubius Therapeutics, Inc. Director May 12, 2022

Insider Transactions Reported by Natalie Holles:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.